Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 350

1.

Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure.

Tett SE, Saint-Marcoux F, Staatz CE, Brunet M, Vinks AA, Miura M, Marquet P, Kuypers DR, van Gelder T, Cattaneo D.

Transplant Rev (Orlando). 2011 Apr;25(2):47-57. doi: 10.1016/j.trre.2010.06.001. Epub 2010 Dec 28.

PMID:
21190834
[PubMed - indexed for MEDLINE]
2.

Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.

Staatz CE, Tett SE.

Clin Pharmacokinet. 2007;46(1):13-58. Review.

PMID:
17201457
[PubMed - indexed for MEDLINE]
4.

Evalutation of mycophenolic acid systemic exposure by limited sampling strategy in kidney transplant recipients receiving enteric-coated mycophenolate sodium (EC-MPS) and cyclosporine.

Capone D, Tarantino G, Kadilli I, Polichetti G, Basile V, Federico S, Sabbatini M.

Nephrol Dial Transplant. 2011 Sep;26(9):3019-25. doi: 10.1093/ndt/gfq819. Epub 2011 Feb 11.

PMID:
21317409
[PubMed - indexed for MEDLINE]
Free Article
5.

Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus.

Musuamba FT, Rousseau A, Bosmans JL, Senessael JJ, Cumps J, Marquet P, Wallemacq P, Verbeeck RK.

Clin Pharmacokinet. 2009;48(11):745-58. doi: 10.2165/11318060-000000000-00000.

PMID:
19817503
[PubMed - indexed for MEDLINE]
6.

Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease.

Abd Rahman AN, Tett SE, Staatz CE.

Clin Pharmacokinet. 2013 May;52(5):303-31. doi: 10.1007/s40262-013-0039-8. Review.

PMID:
23475567
[PubMed - indexed for MEDLINE]
7.

Population pharmacokinetics of mycophenolic acid : a comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients.

de Winter BC, van Gelder T, Glander P, Cattaneo D, Tedesco-Silva H, Neumann I, Hilbrands L, van Hest RM, Pescovitz MD, Budde K, Mathot RA.

Clin Pharmacokinet. 2008;47(12):827-38. doi: 10.2165/0003088-200847120-00007.

PMID:
19026038
[PubMed - indexed for MEDLINE]
8.

Maximum a posteriori Bayesian estimation of mycophenolic Acid area under the concentration-time curve: is this clinically useful for dosage prediction yet?

Staatz CE, Tett SE.

Clin Pharmacokinet. 2011 Dec 1;50(12):759-72. doi: 10.2165/11596380-000000000-00000. Review.

PMID:
22087863
[PubMed - indexed for MEDLINE]
9.

Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes.

Budde K, Glander P, Krämer BK, Fischer W, Hoffmann U, Bauer S, Grohmann J, Neumayer HH, Arns W.

Transplantation. 2007 Feb 27;83(4):417-24.

PMID:
17318074
[PubMed - indexed for MEDLINE]
10.

Development and validation of limited sampling strategies for the estimation of mycophenolic acid area under the curve in adult kidney and liver transplant recipients receiving concomitant enteric-coated mycophenolate sodium and tacrolimus.

Pawinski T, Luszczynska P, Durlik M, Majchrzak J, Baczkowska T, Chrzanowska M, Sobiak J, Glyda M, Kuriata-Kordek M, Kamińska D, Krajewska M, Klinger M.

Ther Drug Monit. 2013 Dec;35(6):760-9. doi: 10.1097/FTD.0b013e31829b88f5.

PMID:
24192641
[PubMed - indexed for MEDLINE]
11.

Mycophenolic acid exposure after administration of mycophenolate mofetil in the presence and absence of cyclosporin in renal transplant recipients.

Kuypers DR, Ekberg H, Grinyó J, Nashan B, Vincenti F, Snell P, Mamelok RD, Bouw RM.

Clin Pharmacokinet. 2009;48(5):329-41. doi: 10.2165/00003088-200948050-00005.

PMID:
19566116
[PubMed - indexed for MEDLINE]
12.

Enteric-coated mycophenolate sodium delivers bioequivalent MPA exposure compared with mycophenolate mofetil.

Arns W, Breuer S, Choudhury S, Taccard G, Lee J, Binder V, Roettele J, Schmouder R.

Clin Transplant. 2005 Apr;19(2):199-206.

PMID:
15740555
[PubMed - indexed for MEDLINE]
13.

Therapeutic drug monitoring of mycophenolate mofetil and enteric-coated mycophenolate sodium in patients with systemic lupus erythematosus.

Djabarouti S, Duffau P, Lazaro E, Chapouly C, Greib C, Viallard JF, Pellegrin JL, Saux MC, Breilh D.

Expert Opin Pharmacother. 2010 Apr;11(5):689-99. doi: 10.1517/14656561003592144.

PMID:
20210680
[PubMed - indexed for MEDLINE]
14.

Pharmacokinetics and variability of mycophenolic acid from enteric-coated mycophenolate sodium compared with mycophenolate mofetil in de novo heart transplant recipients.

Hummel M, Yonan N, Ross H, Miller LW, Sechaud R, Balez S, Koelle EU, Gerosa G; ERL 2401 Study Group.

Clin Transplant. 2007 Jan-Feb;21(1):18-23.

PMID:
17302587
[PubMed - indexed for MEDLINE]
15.

Pharmacokinetic study of mycophenolate mofetil in patients with systemic lupus erythematosus and design of Bayesian estimator using limited sampling strategies.

Zahr N, Amoura Z, Debord J, Hulot JS, Saint-Marcoux F, Marquet P, Piette JC, Lechat P.

Clin Pharmacokinet. 2008;47(4):277-84.

PMID:
18336056
[PubMed - indexed for MEDLINE]
16.

Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil.

Mourad M, Malaise J, Chaib Eddour D, De Meyer M, König J, Schepers R, Squifflet JP, Wallemacq P.

Clin Chem. 2001 Jan;47(1):88-94.

PMID:
11148182
[PubMed - indexed for MEDLINE]
Free Article
17.

Long-term changes in mycophenolic acid exposure in combination with tacrolimus and corticosteroids are dose dependent and not reflected by trough plasma concentration: a prospective study in 100 de novo renal allograft recipients.

Kuypers DR, Claes K, Evenepoel P, Maes B, Coosemans W, Pirenne J, Vanrenterghem Y.

J Clin Pharmacol. 2003 Aug;43(8):866-80.

PMID:
12953344
[PubMed - indexed for MEDLINE]
18.

Clinical pharmacokinetics of mycophenolate mofetil.

Bullingham RE, Nicholls AJ, Kamm BR.

Clin Pharmacokinet. 1998 Jun;34(6):429-55. Review.

PMID:
9646007
[PubMed - indexed for MEDLINE]
19.

The pharmacokinetics of mycophenolate mofetil in Thai kidney transplant recipients.

Jirasiritham S, Sumethkul V, Mavichak V, Na-Bangchang K.

Transplant Proc. 2004 Sep;36(7):2076-8.

PMID:
15518751
[PubMed - indexed for MEDLINE]
20.

Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine.

Lobritto SJ, Rosenthal P, Bouw R, Leung M, Snell P, Mamelok RD.

Liver Transpl. 2007 Nov;13(11):1570-5.

PMID:
17969194
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk